(February 18 02:28) Forbes.com
Most of the adverse outcomes we’ve attributed to the new SARS-CoV-2 variants, we trace back to point mutations located in the receptor binding domain. But they also have mutations in the N-terminal domain that we’d be remiss to neglect.
You can find the original article
here